LINC00035 Transcriptional Regulation of SLC16A3 via CEBPB Affects Glycolysis and Cell Apoptosis in Ovarian Cancer.

Yang S, Wang J, Cheng R, Pang B, Sun P

Open source

DOI
10.1155/2021/5802082
Published
2021
Container
Evidence-based complementary and alternative medicine : eCAM
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2021/5802082,
  title = {LINC00035 Transcriptional Regulation of SLC16A3 via CEBPB Affects Glycolysis and Cell Apoptosis in Ovarian Cancer.},
  author = {Yang S and Wang J and Cheng R and Pang B and Sun P},
  year = {2021},
  journal = {Evidence-based complementary and alternative medicine : eCAM},
  doi = {10.1155/2021/5802082},
  url = {https://doi.org/10.1155/2021/5802082}
}

RIS

TY  - JOUR
TI  - LINC00035 Transcriptional Regulation of SLC16A3 via CEBPB Affects Glycolysis and Cell Apoptosis in Ovarian Cancer.
AU  - Yang S
AU  - Wang J
AU  - Cheng R
AU  - Pang B
AU  - Sun P
PY  - 2021
JO  - Evidence-based complementary and alternative medicine : eCAM
DO  - 10.1155/2021/5802082
UR  - https://doi.org/10.1155/2021/5802082
ER  - 

APA

S, Y., J, W., R, C., B, P., & P, S. (2021). LINC00035 Transcriptional Regulation of SLC16A3 via CEBPB Affects Glycolysis and Cell Apoptosis in Ovarian Cancer.. Evidence-based complementary and alternative medicine : eCAM. https://doi.org/10.1155/2021/5802082

Source records